257 related articles for article (PubMed ID: 20027305)
1. Androgen regulated genes in human prostate xenografts in mice: relation to BPH and prostate cancer.
Love HD; Booton SE; Boone BE; Breyer JP; Koyama T; Revelo MP; Shappell SB; Smith JR; Hayward SW
PLoS One; 2009 Dec; 4(12):e8384. PubMed ID: 20027305
[TBL] [Abstract][Full Text] [Related]
2. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of benign prostatic hyperplasia using a large scale real-time reverse transcriptase-polymerase chain reaction approach.
Fromont G; Chene L; Latil A; Bieche I; Vidaud M; Vallancien G; Mangin P; Fournier G; Validire P; Cussenot O
J Urol; 2004 Oct; 172(4 Pt 1):1382-5. PubMed ID: 15371850
[TBL] [Abstract][Full Text] [Related]
4. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of novel androgen-regulated genes in prostate cancer.
Velasco AM; Gillis KA; Li Y; Brown EL; Sadler TM; Achilleos M; Greenberger LM; Frost P; Bai W; Zhang Y
Endocrinology; 2004 Aug; 145(8):3913-24. PubMed ID: 15131019
[TBL] [Abstract][Full Text] [Related]
6. Gene expression of androgen metabolising enzymes in benign and malignant prostatic tissues.
Khvostova EP; Otpuschennikov AA; Pustylnyak VO; Gulyaeva LF
Horm Metab Res; 2015 Feb; 47(2):119-24. PubMed ID: 24810473
[TBL] [Abstract][Full Text] [Related]
7. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
[TBL] [Abstract][Full Text] [Related]
8. Myosin heavy chain gene expression in normal and hyperplastic human prostate tissue.
Lin VK; Wang D; Lee IL; Vasquez D; Fagelson JE; McConnell JD
Prostate; 2000 Aug; 44(3):193-203. PubMed ID: 10906735
[TBL] [Abstract][Full Text] [Related]
9. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
10. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
11. Gene expression of forkhead transcription factors in the normal and diseased human prostate.
van der Heul-Nieuwenhuijsen L; Dits NF; Jenster G
BJU Int; 2009 Jun; 103(11):1574-80. PubMed ID: 19220249
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues.
Wei H; Desouki MM; Lin S; Xiao D; Franklin RB; Feng P
Mol Cancer; 2008 Jan; 7():7. PubMed ID: 18208603
[TBL] [Abstract][Full Text] [Related]
13. The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia.
O'Malley KJ; Dhir R; Nelson JB; Bost J; Lin Y; Wang Z
Prostate; 2009 Dec; 69(16):1716-23. PubMed ID: 19676094
[TBL] [Abstract][Full Text] [Related]
14. 5α-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.
Godoy A; Kawinski E; Li Y; Oka D; Alexiev B; Azzouni F; Titus MA; Mohler JL
Prostate; 2011 Jul; 71(10):1033-46. PubMed ID: 21557268
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia.
Stamey TA; Warrington JA; Caldwell MC; Chen Z; Fan Z; Mahadevappa M; McNeal JE; Nolley R; Zhang Z
J Urol; 2001 Dec; 166(6):2171-7. PubMed ID: 11696729
[TBL] [Abstract][Full Text] [Related]
17. De novo steroid biosynthesis in human prostate cell lines and biopsies.
Sakai M; Martinez-Arguelles DB; Aprikian AG; Magliocco AM; Papadopoulos V
Prostate; 2016 May; 76(6):575-87. PubMed ID: 26841972
[TBL] [Abstract][Full Text] [Related]
18. Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.
Matos AR; Coutinho-Camillo CM; Thuler LC; Fonseca FP; Soares FA; Silva EA; Gimba ER
Exp Mol Pathol; 2013 Jun; 94(3):438-44. PubMed ID: 23470460
[TBL] [Abstract][Full Text] [Related]
19. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived tissue slice grafts accurately depict response of high-risk primary prostate cancer to androgen deprivation therapy.
Zhao H; Thong A; Nolley R; Reese SW; Santos J; Ingels A; Peehl DM
J Transl Med; 2013 Aug; 11():199. PubMed ID: 23985008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]